Market Tracker

06/21 5:15pm ET

Repligen Corp (NASDAQ:RGEN)

45.60
Delayed Data
As of 4:00pm ET
 -0.38 / -0.83%
Today’s Change
29.56
Today|||52-Week Range
46.81
+25.69%
Year-to-Date
No recent news for Repligen Corp.

Today’s Trading

Previous close45.98
Today’s open46.11
Day’s range45.39 - 46.11
Volume254,670
Average volume (3 months)295,544
Market cap$1.8B
Data as of 4:00pm ET, 06/21/2018

Growth & Valuation

Earnings growth (last year)+111.76%
Earnings growth (this year)+2.21%
Earnings growth (next 5 years)+18.00%
Revenue growth (last year)+35.10%
P/E ratio64.2
Price/Sales10.06
Price/Book3.10

Competitors

 Today’s
change
Today’s
% change
AMRXAmneal Pharmaceutica...-1.17-6.42%
ARRYArray Biopharma Inc-0.44-2.20%
LXRXLexicon Pharmaceutic...-0.62-4.53%
CBMCambrex Corp+0.80+1.72%
Data as of 4:02pm ET, 06/21/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)$0.19
Annual revenue (last year)$141.2M
Annual profit (last year)$28.4M
Net profit margin20.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Tony J. Hunt
Vice President-
Global Operations
Steve Curran
Corporate headquarters
Waltham, Massachusetts

Forecasts